| Authors: |
Stuart BD; Global Health, Biomedical Research, Novartis, Emeryville, California, USA., Stevenson K; Biostatistics Early Development, Biomedical Research, Novartis, Cambridge, Massachusetts, USA., Tillmann HC; Translational Medicine, Biomedical Research, Novartis Pharmaceuticals, Basel, Switzerland., Middleton C; Clinical Sciences and Innovation, Biomedical Research, Novartis, Cambridge, Massachusetts, USA., Nguyen A; Clinical Sciences and Innovation, Biomedical Research, Novartis, Cambridge, Massachusetts, USA., Jumani RS; Global Health, Biomedical Research, Novartis, Emeryville, California, USA., Zhao X; Biomarker Development, Biomedical Research, Novartis, Cambridge, Massachusetts, USA., Blais J; Global Health, Biomedical Research, Novartis, Emeryville, California, USA., Braud-Perez S; Regulatory Affairs, Novartis Pharmaceuticals, Basel, Switzerland., Zhang Y; Biostatistics Early Development, Biomedical Research, Novartis, East Hanover, New Jersey, USA., Etse J; Technical Research and Development, Novartis Pharmaceuticals, East Hanover, New Jersey, USA., Arora K; Global Health, Biomedical Research, Novartis, Emeryville, California, USA., Aziz N; Global Health, Biomedical Research, Novartis, Emeryville, California, USA., Mohamed AI; Pharmaron, Clinical Development, Baltimore, Maryland, USA., Diagana TT; Global Health, Biomedical Research, Novartis, Emeryville, California, USA., Manjunatha UH; Global Health, Biomedical Research, Novartis, Emeryville, California, USA. |
